1/2/18
Sanofi Pasteur announced on December 27th that the FDA approved Vaxelis, a Diphtheria, Tetanus Toxoids, Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate, and Hepatitis B Vaccine) indicated for children 6 weeks to 4 years. VAXELIS was developed in partnership with Merck. Dtap – IPV – HIB – HepB.